Small-molecule ligands specific for prostate-specific membrane antigen (PSMA) have the potential to improve prostate cancer imaging. However, highly charged ligands are difficult to label with 99mTc and to purify. In this study, we present an adamantane-trimerized small molecule that has nanomolar binding to PSMA and also has 12 negative charges. Methods: To convert this molecule into a clinically viable SPECT diagnostic, we have de-veloped a simple, cartridge-based, solid-phase prelabeling strategy that, within 25 min, converts readily available and inex-pensive 99mTc-pertechnetate into a chemically pure complex, with a reactive N-hydroxysuccinimide (NHS) ester, in neat or-ganic solvent. This stable intermediate can label any amine-contain...
Because traditional endpoints in oncology trials are not always applicable for metastatic prostate c...
textabstractProstate-specific membrane antigen (PSMA) is overexpressed in prostate cancer (PCa) and ...
Prostate-specific Membrane Antigen (PSMA) is overexpressed in prostate cancer (PCa) and a promising ...
Small-molecule ligands specific for prostate-specific membrane antigen (PSMA) have the potential to ...
Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer, and small-molecule...
Prostate cancer (PCa) is the second tumor most diagnosed in men and their sixth cause of death world...
Thesis (Ph.D.), Department of Chemistry, Washington State UniversityThe cell-surface enzyme prostate...
This phase 1 study was performed to determine the pharmacoki-netics and ability to visualize prostat...
Since prostate-specific membrane antigen (PSMA) has been identified as a diagnostic target for prost...
Prostate-specific membrane antigen (PSMA), a type II glycoprotein, is highly expressed in almost all...
Prostate-specific membrane antigen (PSMA), a type II glycoprotein, is highly expressed in almost all...
Radiohalogenated agents are often the first line of pursuit in the development of new radiopharmaceu...
Prostate cancer surgery is currently being revolutionized by the use of prostate-specific membrane a...
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer (PCa) and a promising ...
Background: The rising incidence rate of prostate cancer (PCa) has promoted the development of new d...
Because traditional endpoints in oncology trials are not always applicable for metastatic prostate c...
textabstractProstate-specific membrane antigen (PSMA) is overexpressed in prostate cancer (PCa) and ...
Prostate-specific Membrane Antigen (PSMA) is overexpressed in prostate cancer (PCa) and a promising ...
Small-molecule ligands specific for prostate-specific membrane antigen (PSMA) have the potential to ...
Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer, and small-molecule...
Prostate cancer (PCa) is the second tumor most diagnosed in men and their sixth cause of death world...
Thesis (Ph.D.), Department of Chemistry, Washington State UniversityThe cell-surface enzyme prostate...
This phase 1 study was performed to determine the pharmacoki-netics and ability to visualize prostat...
Since prostate-specific membrane antigen (PSMA) has been identified as a diagnostic target for prost...
Prostate-specific membrane antigen (PSMA), a type II glycoprotein, is highly expressed in almost all...
Prostate-specific membrane antigen (PSMA), a type II glycoprotein, is highly expressed in almost all...
Radiohalogenated agents are often the first line of pursuit in the development of new radiopharmaceu...
Prostate cancer surgery is currently being revolutionized by the use of prostate-specific membrane a...
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer (PCa) and a promising ...
Background: The rising incidence rate of prostate cancer (PCa) has promoted the development of new d...
Because traditional endpoints in oncology trials are not always applicable for metastatic prostate c...
textabstractProstate-specific membrane antigen (PSMA) is overexpressed in prostate cancer (PCa) and ...
Prostate-specific Membrane Antigen (PSMA) is overexpressed in prostate cancer (PCa) and a promising ...